Related references
Note: Only part of the references are listed.Role of B Cells in Multiple Sclerosis and Related Disorders
Giancarlo Comi et al.
ANNALS OF NEUROLOGY (2021)
CD20+ T Cells as Pathogenic Players and Therapeutic Targets in MS
Edgar Meinl et al.
ANNALS OF NEUROLOGY (2021)
CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS
Gaurav Kumar et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Proinflammatory CD20+ T Cells are Differentially Affected by Multiple Sclerosis Therapeutics
Corinna Quendt et al.
ANNALS OF NEUROLOGY (2021)
APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans
Dimitrios Tsiantoulas et al.
NATURE (2021)
Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders
Simone Brioschi et al.
SCIENCE (2021)
Regulation of neuroinflammation by B cells and plasma cells
Angela Wang et al.
IMMUNOLOGICAL REVIEWS (2021)
Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis
Anne-Katrin Probstel et al.
SCIENCE IMMUNOLOGY (2020)
BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid
Mahya Eslami et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10 (vol 176, pg 610, 2019)
Olga L. Rojas et al.
CELL (2019)
APRIL Induces a Novel Subset of IgA+ Regulatory B Cells That Suppress Inflammation via Expression of IL-10 and PD-L1
Cynthia M. Fehres et al.
FRONTIERS IN IMMUNOLOGY (2019)
Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus Monkeys
Diethilde Theil et al.
FRONTIERS IN IMMUNOLOGY (2019)
B cells in autoimmune and neurodegenerative central nervous system diseases
Joseph J. Sabatino et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis
Joseph J. Sabatino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis
Laurie Baert et al.
ANNALS OF NEUROLOGY (2019)
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
Darius Haeusler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Shedding of BAFF/APRIL Receptors Controls B Cells
Edgar Meinl et al.
TRENDS IN IMMUNOLOGY (2018)
A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cells
Charlotte Hua et al.
JOURNAL OF AUTOIMMUNITY (2016)
Features of Human CD3+CD20+ T Cells
Elisabeth Schuh et al.
JOURNAL OF IMMUNOLOGY (2016)
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
Robert C. Sergott et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
γ-secretase directly sheds the survival receptor BCMA from plasma cells
Sarah A. Laurent et al.
NATURE COMMUNICATIONS (2015)
The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity
Franziska S. Hoffmann et al.
JOURNAL OF IMMUNOLOGY (2015)
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
Arumugam Palanichamy et al.
JOURNAL OF IMMUNOLOGY (2014)
Soluble BAFF Levels Inversely Correlate with Peripheral B Cell Numbers and the Expression of BAFF Receptors
Matthias Kreuzaler et al.
JOURNAL OF IMMUNOLOGY (2012)
B cells and antibodies in multiple sclerosis pathogenesis and therapy
Markus Krumbholz et al.
NATURE REVIEWS NEUROLOGY (2012)
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice
Susan S. Kim et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
H. L. Pellkofer et al.
NEUROLOGY (2011)
Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab
Henrik E. Mei et al.
BLOOD (2010)
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts
Claudia Bossen et al.
BLOOD (2008)
Structures of APRIL-receptor complexes - Like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding
SG Hymowitz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA
ES Day et al.
BIOCHEMISTRY (2005)
Impaired IgA class switching in APRIL-deficient mice
E Castigli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases
S Xanthoulea et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Share Paper
